腹部脂胖症（Abdominal Obesity）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Abdominal Obesity 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Abdominal Obesity 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Abdominal Obesity Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Abdominal Obesity 32
Sep 30, 2013: Lithera Reports Positive Clinical Study Results From Its Phase 2b RESET Trial for LIPO-202, a Novel Treatment for Abdominal Body Contouring 32
May 07, 2013: Aileron Therapeutics Successfully Completes Stapled Peptide Clinical Trial 32
Mar 12, 2013: Lithera Initiates Phase IIb Clinical Trial Of LIPO-202 Targeting Aesthetic Reduction Of Subcutaneous Abdominal Fat 33
May 10, 2012: Theratechnologies Initiates Preclinical Safety Program For New GRF Peptide, TH1173 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Genfit SA 34
Clinical Trial Overview of Genfit SA 34
Lithera, Inc. 35
Clinical Trial Overview of Lithera, Inc. 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
Hanmi Science Co., Ltd. 39
Clinical Trial Overview of Hanmi Science Co., Ltd. 39
Parry Nutraceuticals 40
Clinical Trial Overview of Parry Nutraceuticals 40
Kythera Biopharmaceuticals, Inc. 41
Clinical Trial Overview of Kythera Biopharmaceuticals, Inc. 41
Johnson & Johnson 42
Clinical Trial Overview of Johnson & Johnson 42
Clinical Trial Overview of Top Institutes / Government 43
Queen’s University 43
Clinical Trial Overview of Queen’s University 43
Massachusetts General Hospital 44
Clinical Trial Overview of Massachusetts General Hospital 44
University of Pittsburgh 45
Clinical Trial Overview of University of Pittsburgh 45
Wake Forest University 46
Clinical Trial Overview of Wake Forest University 46
Baker IDI Heart and Diabetes Institute 47
Clinical Trial Overview of Baker IDI Heart and Diabetes Institute 47
Rush University Medical Center 48
Clinical Trial Overview of Rush University Medical Center 48
UMC Utrecht Holding BV 49
Clinical Trial Overview of UMC Utrecht Holding BV 49
Southeast University 50
Clinical Trial Overview of Southeast University 50
Washington University School of Medicine 51
Clinical Trial Overview of Washington University School of Medicine 51
Maastricht University Medical Center 52
Clinical Trial Overview of Maastricht University Medical Center 52
Five Key Clinical Profiles 53
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 107